Review waiting, please be patient.
This may take 3 months or more, since drafts are reviewed in no specific order. There are 2,903 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 18 April 2024 by Xkalponik (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. |
Submission declined on 13 March 2024 by Kline (talk). This submission does not appear to be written in the formal tone expected of an encyclopedia article. Entries should be written from a neutral point of view, and should refer to a range of independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid peacock terms that promote the subject. Declined by Kline 2 months ago. |
Submission declined on 4 February 2024 by Xegma (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by Xegma 3 months ago. |
Submission declined on 24 January 2024 by Rich Smith (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. The content of this submission includes material that does not meet Wikipedia's minimum standard for inline citations. Please cite your sources using footnotes. For instructions on how to do this, please see Referencing for beginners. Thank you. Declined by Rich Smith 4 months ago. |
Submission declined on 10 October 2023 by Rich Smith (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. The content of this submission includes material that does not meet Wikipedia's minimum standard for inline citations. Please cite your sources using footnotes. For instructions on how to do this, please see Referencing for beginners. Thank you. Declined by Rich Smith 7 months ago. |
Robert Colebunders | |
---|---|
Born | 19 April 1950 |
Nationality | Belgian |
Alma mater | University of Antwerp Free University of Brussels Institute of Tropical Medicine Antwerp |
Scientific career | |
Fields | Infectious Diseases |
Institutions | Global Health Institute University of Antwerp Institute of Tropical Medicine Antwerp |
Website | uantwerpen |
Prof. Emeritus Robert Colebunders (born 19 April 1950) is a Belgian clinician and researcher specialised in infectious diseases. He has contributed to the study and management of various pathogens, including Ebola, AIDS, tuberculosis and, more recently, COVID-19, monkeypox and onchocerciasis.
Colebunders investigated significant disease outbreaks like the Kikwit Ebola Virus[1] and Durba Marburg Virus outbreaks[2], contributing to the advancement of understanding and management of these deadly pathogens. During the 1980s, Colebunders' research helped defining the clinical manifestations of HIV infection in Africa[3][4] and developing diagnostic tests for the virus[5]. This work laid the foundation for further advancements in HIV/AIDS diagnosis, treatment and surveillance.
Throughout his career, Colebunders has focused on improving patient outcomes, particularly in resource-limited settings. His studies on enhancing the quality of care for individuals living with HIV[6] and HIV/tuberculosis co-infection[7] have had a positive impact on clinical practice. Colebunders' efforts in organising and coordinating care and treatment strategies for HIV have contributed to more effective healthcare delivery models, benefiting affected persons worldwide[8].
In response to emerging infectious threats, Colebunders has been actively involved in research initiatives to understand and combat diseases such as COVID-19 and monkeypox. His studies on COVID-19 epidemiology in low- and middle-income countries[9] and contributions to defining post-COVID conditions have informed global response efforts and public health policies[10]. He also participated in monkeypox research[11] during the 2022-2023 outbreak[12].
Currently, Colebunders leads research on onchocerciasis-associated epilepsy (OAE), a debilitating condition found in regions where onchocerciasis is endemic[13]. Through collaborative efforts, he is advancing the understanding of the intricate relationship between onchocerciasis and epilepsy, termed onchocerciasis-associated epilepsy (OAE), and developing approaches for disease prevention and management[14]. Notably, his research has shown the potential effectiveness of onchocerciasis control programmes in preventing new OAE cases[15][16][17], highlighting the importance of integrated public health strategies.
Colebunders' work has also explored the potential link between OAE and conditions like Nodding syndrome and Nakalanga syndrome[18]. Additionally, he has developed practical interventions for managing individuals with OAE, inclduing providing antiseizure medication and addressing the stigma associated with epilepsy[19][20][21][22].